세계의 일회용 바이오리액터 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 유형별, 세포 유형별, 분자 유형별, 용도별, 최종 용도별, 사용 단계별, 지역별), 부문별 예측(2025-2033년)

Single-use Bioreactors Market Summary

The global single-use bioreactors market size was estimated at USD 4.58 billion in 2024 and is projected to reach USD 18.65 billion by 2033, growing at a CAGR of 17.12% from 2025 to 2033. Single-use systems are emerging as an important technology for pharmaceutical and mammalian cell culture applications.

They are particularly well-suited for biopharmaceutical production, where prevailing market trends call for quick, easy, and flexible deployment. In addition, with comprehensive qualification and validation procedures, the use of single-use bioreactors lowers the possibility of cross-contamination and improves process safety in highly potent biopharmaceutical compounds. These factors are anticipated to drive the market growth.

In addition, some of the manufacturers are using bioreactors to culture suitable host cells for the coronavirus, in order to study the viral pathogenesis in humans. Moreover, in the past few months, the single-use bioreactor manufacturers have undertaken numerous collaborative initiatives to develop biologics/vaccines as potential therapeutics against the COVID-19. For instance, ABEC has focused on customizing the process services and solutions throughout the manufacturing and development of the entire range of biopharmaceutical products, with the aid of its single-use solutions.

The range of stainless-steel bioreactors and associated high capital costs have become a challenge due to the changing demand for biopharmaceuticals. SUBs' versatility to meet the rising demand for biopharmaceuticals has enabled them to successfully address the issues related to traditional bioreactors. Flexibility offered by single-use bioreactors is one of the main encouraging factors for investing in technology that further drives the growth of the single-use bioreactors industry.

Additionally, it is projected that in the upcoming years, the use of disposable bioreactors will pick up steam due to the increased demand for biopharmaceuticals across the globe. Small-scale, bench-top SUBs reduce the requirement for assembling, cleaning, and autoclaving, which leads to quicker turnaround times. The advantages offered by SUBs motivate their use for the manufacturing of biopharmaceuticals.

Global Single-use Bioreactors Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the single-use bioreactors market on the basis of product, type, type of cell, molecule type, application, end use, usage type, and region:

• Product Scope Outlook (Revenue, USD Million, 2021 - 2033)
• Single-use bioreactor systems
  • Up to 10L
  • 11-100L
  • 101-500L
  • 501-1500L
  • Above 1500L
• Single-use media bags
  • 2D Bags
  • 3D Bags
  • Others
• Single-use Filtration Assemblies
• Other Products
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Stirred-tank SUBs
• Wave-induced SUBs
• Bubble-column SUBs
• Other SUBs
• Type of Cell Outlook (Revenue, USD Million, 2021 - 2033)
• Mammalian Cells
• Bacterial Cells
• Yeast Cells
• Other Cells
• Molecule Type Outlook (Revenue, USD Million, 2021 - 2033)
• Monoclonal Antibodies
• Vaccines
• Gene Modified Cells
• Stem Cells
• Other Molecules
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Research and Development (R&D) or Process Development
• Bioproduction
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biopharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutes
• Usage Type Outlook (Revenue, USD Million, 2021 - 2033)
• Lab-scale Production
• Pilot-scale Production
• Large-scale Production
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Australia
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. Type of Cell
  • 1.2.4. Molecule Type
  • 1.2.5. Application
  • 1.2.6. End Use
  • 1.2.7. Usage Type
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Landscape Snapshot

Chapter 3. Single-use Bioreactors Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing adoption of SUBs among small companies and startups
    • 3.2.1.2. Technological advancements in SUBs
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Regulatory Concerns related to single-use bioreactors
• 3.3. Industry Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

• 4.1. Segment Dashboard
• 4.2. Single-use Bioreactors Market: Product Movement Analysis
• 4.3. Single-use Bioreactor Systems
  • 4.3.1. Single-use bioreactor systems market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.3.2. Up to 10L
    • 4.3.2.1. Up to 10L market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.3.3. 11-100L
    • 4.3.3.1. 11-100L market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.3.4. 101-500L
    • 4.3.4.1. 101-500L market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.3.5. 501-1500L
    • 4.3.5.1. 501-1500L market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.3.6. Above 1500L
    • 4.3.6.1. Above 1500L market estimates and forecasts 2021 - 2033 (USD Million)
• 4.4. Single-use Media Bags
  • 4.4.1. Single-use media bags market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.4.2. 2D Bags
    • 4.4.2.1. 2D bags market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.4.3. 3D Bags
    • 4.4.3.1. 3D bags market estimates and forecasts 2021 - 2033 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others market estimates and forecasts 2021 - 2033 (USD Million)
• 4.5. Single-use Filtration Assemblies
  • 4.5.1. Single-use filtration assemblies market estimates and forecasts 2021 - 2033 (USD Million)
• 4.6. Other Products
  • 4.6.1. Other products market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 5. Type Business Analysis

• 5.1. Segment Dashboard
• 5.2. Single-use Bioreactors Market: Type Movement Analysis
• 5.3. Stirred-tank SUBs
  • 5.3.1. Stirred-tank SUBs market estimates and forecasts 2021 - 2033 (USD Million)
• 5.4. Wave-induced SUBs
  • 5.4.1. Wave-induced SUBs market estimates and forecasts 2021 - 2033 (USD Million)
• 5.5. Bubble-column SUBs
  • 5.5.1. Bubble-column SUBs market estimates and forecasts 2021 - 2033 (USD Million)
• 5.6. Other SUBs
  • 5.6.1. Other SUBs market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 6. Type of Cell Business Analysis

• 6.1. Segment Dashboard
• 6.2. Single-use Bioreactors Market: Type of Cell Movement Analysis
• 6.3. Mammalian Cells
  • 6.3.1. Mammalian cells market estimates and forecasts 2021 - 2033 (USD Million)
• 6.4. Bacterial Cells
  • 6.4.1. Bacterial cells market estimates and forecasts 2021 - 2033 (USD Million)
• 6.5. Yeast Cells
  • 6.5.1. Yeast cells market estimates and forecasts 2021 - 2033 (USD Million)
• 6.6. Other Cells
  • 6.6.1. Other cells market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 7. Molecule Type Business Analysis

• 7.1. Segment Dashboard
• 7.2. Single-use Bioreactors Market: Molecule Type Movement Analysis
• 7.3. Monoclonal Antibodies
  • 7.3.1. Monoclonal antibodies market estimates and forecasts 2021 - 2033 (USD Million)
• 7.4. Vaccines
  • 7.4.1. Vaccines market estimates and forecasts 2021 - 2033 (USD Million)
• 7.5. Gene Modified Cells
  • 7.5.1. Gene modified cells market estimates and forecasts 2021 - 2033 (USD Million)
• 7.6. Stem Cells
  • 7.6.1. Stem cells market estimates and forecasts 2021 - 2033 (USD Million)
• 7.7. Other Molecules
  • 7.7.1. Other molecules market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 8. Application Business Analysis

• 8.1. Segment Dashboard
• 8.2. Single-use Bioreactors Market: Application Movement Analysis
• 8.3. Research and Development (R&D) or Process Development
  • 8.3.1. Research and development (R&D) or process development market estimates and forecasts 2021 - 2033 (USD Million)
• 8.4. Bioproduction
  • 8.4.1. Bioproduction market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 9. End Use Business Analysis

• 9.1. Segment Dashboard
• 9.2. Single-use Bioreactors Market: End Use Movement Analysis
• 9.3. Pharmaceutical & Biopharmaceutical Companies
  • 9.3.1. Pharmaceutical & biopharmaceutical companies market estimates and forecasts 2021 - 2033 (USD Million)
• 9.4. CROs & CMOs
  • 9.4.1. CROs & CMOs market estimates and forecasts 2021 - 2033 (USD Million)
• 9.5. Academic & Research Institutes
  • 9.5.1. Academic & research institutes market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 10. Usage Type Business Analysis

• 10.1. Segment Dashboard
• 10.2. Single-use Bioreactors Market: Usage Type Movement Analysis
• 10.3. Lab-Scale Production
  • 10.3.1. Lab-scale production market estimates and forecasts 2021 - 2033 (USD Million)
• 10.4. Pilot-Scale Production
  • 10.4.1. Pilot-scale production market estimates and forecasts 2021 - 2033 (USD Million)
• 10.5. Large-Scale Production
  • 10.5.1. Large-scale production market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 11. Regional Business Analysis

• 11.1. Regional Dashboard
• 11.2. Single-use Bioreactors Market: Regional Outlook
• 11.3. North America
  • 11.3.1. North America market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.3.2. U.S.
    • 11.3.2.1. Key country dynamics
    • 11.3.2.2. Competitive scenario
    • 11.3.2.3. Regulatory framework
    • 11.3.2.4. U.S. market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.3.3. Canada
    • 11.3.3.1. Key country dynamics
    • 11.3.3.2. Competitive scenario
    • 11.3.3.3. Regulatory framework
    • 11.3.3.4. Canada market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.3.4. Mexico
    • 11.3.4.1. Key country dynamics
    • 11.3.4.2. Competitive scenario
    • 11.3.4.3. Regulatory framework
    • 11.3.4.4. Mexico market estimates and forecasts 2021 - 2033 (USD Million)
• 11.4. Europe
  • 11.4.1. Europe market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.4.2. UK
    • 11.4.2.1. Key country dynamics
    • 11.4.2.2. Competitive scenario
    • 11.4.2.3. Regulatory framework
    • 11.4.2.4. UK market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.4.3. Germany
    • 11.4.3.1. Key country dynamics
    • 11.4.3.2. Competitive scenario
    • 11.4.3.3. Regulatory framework
    • 11.4.3.4. Germany market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.4.4. France
    • 11.4.4.1. Key country dynamics
    • 11.4.4.2. Competitive scenario
    • 11.4.4.3. Regulatory framework
    • 11.4.4.4. France market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.4.5. Italy
    • 11.4.5.1. Key country dynamics
    • 11.4.5.2. Competitive scenario
    • 11.4.5.3. Regulatory framework
    • 11.4.5.4. Italy market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.4.6. Spain
    • 11.4.6.1. Key country dynamics
    • 11.4.6.2. Competitive scenario
    • 11.4.6.3. Regulatory framework
    • 11.4.6.4. Spain market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.4.7. Norway
    • 11.4.7.1. Key country dynamics
    • 11.4.7.2. Competitive scenario
    • 11.4.7.3. Regulatory framework
    • 11.4.7.4. Norway market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.4.8. Sweden
    • 11.4.8.1. Key country dynamics
    • 11.4.8.2. Competitive scenario
    • 11.4.8.3. Regulatory framework
    • 11.4.8.4. Sweden market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.4.9. Denmark
    • 11.4.9.1. Key country dynamics
    • 11.4.9.2. Competitive scenario
    • 11.4.9.3. Regulatory framework
    • 11.4.9.4. Denmark market estimates and forecasts 2021 - 2033 (USD Million)
• 11.5. Asia Pacific
  • 11.5.1. Asia Pacific market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.5.2. Japan
    • 11.5.2.1. Key country dynamics
    • 11.5.2.2. Competitive scenario
    • 11.5.2.3. Regulatory framework
    • 11.5.2.4. Japan market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.5.3. China
    • 11.5.3.1. Key country dynamics
    • 11.5.3.2. Competitive scenario
    • 11.5.3.3. Regulatory framework
    • 11.5.3.4. China market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.5.4. India
    • 11.5.4.1. Key country dynamics
    • 11.5.4.2. Competitive scenario
    • 11.5.4.3. Regulatory framework
    • 11.5.4.4. India market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.5.5. Australia
    • 11.5.5.1. Key country dynamics
    • 11.5.5.2. Competitive scenario
    • 11.5.5.3. Regulatory framework
    • 11.5.5.4. Australia market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.5.6. South Korea
    • 11.5.6.1. Key country dynamics
    • 11.5.6.2. Competitive scenario
    • 11.5.6.3. Regulatory framework
    • 11.5.6.4. South Korea market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.5.7. Thailand
    • 11.5.7.1. Key country dynamics
    • 11.5.7.2. Competitive scenario
    • 11.5.7.3. Regulatory framework
    • 11.5.7.4. Thailand market estimates and forecasts 2021 - 2033 (USD Million)
• 11.6. Latin America
  • 11.6.1. Latin America market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.6.2. Brazil
    • 11.6.2.1. Key country dynamics
    • 11.6.2.2. Competitive scenario
    • 11.6.2.3. Regulatory framework
    • 11.6.2.4. Brazil market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.6.3. Argentina
    • 11.6.3.1. Key country dynamics
    • 11.6.3.2. Competitive scenario
    • 11.6.3.3. Regulatory framework
    • 11.6.3.4. Argentina market estimates and forecasts 2021 - 2033 (USD Million)
• 11.7. MEA
  • 11.7.1. MEA market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.7.2. South Africa
    • 11.7.2.1. Key country dynamics
    • 11.7.2.2. Competitive scenario
    • 11.7.2.3. Regulatory framework
    • 11.7.2.4. South Africa market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.7.3. Saudi Arabia
    • 11.7.3.1. Key country dynamics
    • 11.7.3.2. Competitive scenario
    • 11.7.3.3. Regulatory framework
    • 11.7.3.4. Saudi Arabia market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.7.4. UAE
    • 11.7.4.1. Key country dynamics
    • 11.7.4.2. Competitive scenario
    • 11.7.4.3. Regulatory framework
    • 11.7.4.4. UAE market estimates and forecasts 2021 - 2033 (USD Million)
  • 11.7.5. Kuwait
    • 11.7.5.1. Key country dynamics
    • 11.7.5.2. Competitive scenario
    • 11.7.5.3. Regulatory framework
    • 11.7.5.4. Kuwait market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 12. Competitive Landscape

• 12.1. Company Categorization
• 12.2. Strategy Mapping
• 12.3. Company Market Position Analysis, 2024
• 12.4. Company Profiles/Listing
  • 12.4.1. Sartorius Inc.
    • 12.4.1.1. Company overview
    • 12.4.1.2. Financial performance
    • 12.4.1.3. Product benchmarking
    • 12.4.1.4. Strategic initiatives
  • 12.4.2. Thermo Fisher Scientific Inc.
    • 12.4.2.1. Company overview
    • 12.4.2.2. Financial performance
    • 12.4.2.3. Product benchmarking
    • 12.4.2.4. Strategic initiatives
  • 12.4.3. Danaher
    • 12.4.3.1. Company overview
    • 12.4.3.2. Financial performance
    • 12.4.3.3. Product benchmarking
    • 12.4.3.4. Strategic initiatives
  • 12.4.4. Merck KgaA
    • 12.4.4.1. Company overview
    • 12.4.4.2. Financial performance
    • 12.4.4.3. Product benchmarking
    • 12.4.4.4. Strategic initiatives
  • 12.4.5. Celltainer Biotech BV
    • 12.4.5.1. Company overview
    • 12.4.5.2. Financial performance
    • 12.4.5.3. Product benchmarking
    • 12.4.5.4. Strategic initiatives
  • 12.4.6. Getinge AB
    • 12.4.6.1. Company overview
    • 12.4.6.2. Financial performance
    • 12.4.6.3. Product benchmarking
    • 12.4.6.4. Strategic initiatives
  • 12.4.7. Eppendorf AG
    • 12.4.7.1. Company overview
    • 12.4.7.2. Financial performance
    • 12.4.7.3. Product benchmarking
    • 12.4.7.4. Strategic initiatives
  • 12.4.8. Cellexus
    • 12.4.8.1. Company overview
    • 12.4.8.2. Financial performance
    • 12.4.8.3. Product benchmarking
    • 12.4.8.4. Strategic initiatives
  • 12.4.9. PBS Biotech Inc.
    • 12.4.9.1. Company overview
    • 12.4.9.2. Financial performance
    • 12.4.9.3. Product benchmarking
    • 12.4.9.4. Strategic initiatives
  • 12.4.10. Lonza
    • 12.4.10.1. Company overview
    • 12.4.10.2. Financial performance
    • 12.4.10.3. Product benchmarking
    • 12.4.10.4. Strategic initiatives